China will continue to exhibit strong growth and will be the focus of market expansion from large multinational orthopedic device companies, as well as some of the most successful Chinese medical device companies
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for trauma and reconstructive implant devices in China across a 10-year period.
Geographies Covered: DRG's analysis uses the following breakdown of regions in China:
Notes: PLMs include Beijing, Shanghai, and Tianjin. East coast includes Fujian, Guangdong, Jiangsu, Shandong, and Zhejiang. Central includes Anhui, Hebei, Henan, Hubei, Hunan, Jiangxi, and Shanxi. Other regions include Chongqing, Gansu, Guangxi, Guizhou, Hainan, Heilongjiang, Inner Mongolia, Jilin, Liaoning, Ningxia, Qinghai, Shaanxi, Sichuan, Tibet, Xinjiang, and Yunnan.
Procedures and Products Covered:
Plates and Screws
Reconstructive Joint Implants
Notes: *This segmentation is not provided for procedures and applies to the market breakdowns only. **Other includes tibial, femoral, humeral, radial, ulnar, fibular, hand, foot, and ankle IM nails.
Market Forecast Features: Based on primary research with industry professionals, DRG uses its proprietary forecasting model to provide an in-depth examination of current and future trends in procedure volumes, unit sales, ASPs, and market values over a 10-year period (2012–2022).
Competitive Analysis: DRG provides a detailed analysis of the competitive landscape and market shares for leading competitors.